O2‐11‐05: EFFECTS OF AGGREGATED HUMAN Aβ 1‐42 ON IMMUNE SURVEILLANCE: EX VIVO AND IN VITRO STUDIES (English)
- New search for: Ferretti, Maria Teresa
- New search for: Gericke, Christoph
- New search for: Nitsch, Roger M.
- New search for: Ferretti, Maria Teresa
- New search for: Gericke, Christoph
- New search for: Nitsch, Roger M.
In:
Alzheimer's & Dementia
;
14
, 7S_Part_12
;
P649
;
2018
- Article (Journal) / Electronic Resource
-
Title:O2‐11‐05: EFFECTS OF AGGREGATED HUMAN Aβ 1‐42 ON IMMUNE SURVEILLANCE: EX VIVO AND IN VITRO STUDIES
-
Contributors:
-
Published in:Alzheimer's & Dementia ; 14, 7S_Part_12 ; P649
-
Publisher:
-
Publication date:2018-07-01
-
Size:1 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Source:
Table of contents – Volume 14, Issue 7S_Part_12
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- P647
-
O2‐11‐03: PROGRANULIN LOSS DYSREGULATES SPLENIC AND PERIPHERAL BLOOD IMMUNE CELL POPULATIONS AND MAY CONTRIBUTE TO NEUROINFLAMMATION AND NEURODEGENERATION IN FRONTOTEMPORAL DEMENTIAKukar, Thomas G. / MacPherson, Kathryn P. / Kannarkat, George T. / Kline, Elizabeth M. / Holler, Christopher M. / Johnson, Michelle A. / Taylor, Georgia L. / Oliver, Danielle / Blanchfield, Jennifer Lori / Joers, Valerie L. et al. | 2018
- P647
-
O2‐11‐02: THE ROLE OF SOLUBLE TNF IN METABOLIC DYSFUNCTION AND BBB ALTERATIONS IN A MOUSE MODEL OF ALZHEIMER'S DISEASETansey, Malu G. / MacPherson, Kathryn P. / Eidson, Lori N. / Herrick, Mary K. / Elizabeth de Sousa Rodrigues, Maria / Oliver, Danielle / Kelly, Sean D. / Yang, Yuan / Chang, Jianjun / Sniffen, Lindsey et al. | 2018
- P648
-
O2‐11‐04: QUANTIFICATION OF WHITE MATTER CELLULARITY IN PRECLINICAL AND EARLY SYMPTOMATIC ALZHEIMER DISEASE USING NEURO‐IMMNUE IMAGINGWang, Qing / Wang, Yong / Shimony, Joshua S. / Liu, Jingxia / Fagan, Anne M. / Cairns, Nigel J. / Ances, Beau M. / Morris, John C. / Benzinger, Tammie L.S. et al. | 2018
- P649
-
O2‐11‐05: EFFECTS OF AGGREGATED HUMAN Aβ 1‐42 ON IMMUNE SURVEILLANCE: EX VIVO AND IN VITRO STUDIESFerretti, Maria Teresa / Gericke, Christoph / Nitsch, Roger M. et al. | 2018
- P649
-
O2‐11‐06: BLOOD‐BASED PROTEIN PREDICTORS OF DEMENTIA SEVERITY AS MEASURED BY δ: REPLICATION ACROSS BIOFLUIDS AND COHORTSRoyall, Donald R. / Bishnoi, Ram J. / Palmer, Raymond F. / Alzheimer's Disease Neuroimaging Initiative et al. | 2018
- P650
-
O2‐12‐02: A NOVEL LYSOSOME TO MITOCHONDRIA SIGNALING PATHWAY REGULATES MITOCHONDRIAL ACTIVITY AND IS DISRUPTED BY AMYLOID‐β OLIGOMERSNorambuena, Andrés / Wallrabe, Horst / Cao, Rui / Wang, Dora Bigler / Silva, Antonia / Svindrych, Zdenek / Periasamy, Ammasi / Hu, Song / Tanzi, Rudolph E. / Kim, Doo Yeon et al. | 2018
- P650
-
O2‐12‐01: LYSOSOMAL DYSFUNCTION AND ALTERED TAU METABOLISM IN STEM CELL MODELS OF AUTOSOMAL DOMINANT ALZHEIMER'S DISEASEMahali, Sidhartha / Hsu, Simon / Benitez, Bruno / Martinez, Rita / Goate, Alison M. / Karch, Celeste / DIAN et al. | 2018
- P651
-
O2‐12‐03: MUTATIONS IN PSEN GENES ASSOCIATED WITH FAMILIAL FORM OF ALZHEIMER'S DISEASE DISPLAY AN IMPAIRED BLOOD‐BRAIN BARRIER PHENOTYPE IN VITROPatel, Ronak / Al-Ahmad, Abraham J. et al. | 2018
- P651
-
O2‐12‐04: STALLED BLOOD FLOW IN BRAIN CAPILLARIES IS RESPONSIBLE FOR REDUCED CORTICAL PERFUSION AND IMPACTS COGNITIVE FUNCTION IN MOUSE MODELS OF ALZHEIMER'S DISEASEBracko, Oliver / Cruz Hernandez, Jean C. / Njiru, Brendah N. / Swallow, Madison / Zheng, Jieyu / Ali, Muhammad / Kersbergen, Calvin / Muse, Victorine / Haft-Javaherian, Mohammad / Park, Laibaik et al. | 2018
- P652
-
O2‐13‐01: INCIDENCE OF CEREBRAL MICROBLEEDS AND AMYLOID BURDEN: THE MAYO CLINIC STUDY OF AGINGRadford, Jonathan Graff / Vemuri, Prashanthi / Rabinstein, Alejandro / Przybelski, Scott A. / Lesnick, Timothy G. / Flemming, Kelly / Brown, Robert D. / Knopman, David S. / Roberts, Rosebud O. / Mielke, Michelle M. et al. | 2018
- P652
-
O2‐12‐06: NEUROPATHOLOGICAL FINDINGS DRIVEN BY AN APOEε4 LIVER PHENOTYPEPatra, Kalicharan / Giannisis, Andreas / Nielsen, Henrietta M. et al. | 2018
- P652
-
O2‐12‐05: WITHDRAWN| 2018
- P653
-
O2‐13‐02: RELATIONSHIP OF BRAIN STRUCTURE AND GLUCOSE METABOLISM TO VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF)Tubi, Meral A. / Feingold, Franklin W. / Corlier, Fabian W. / Mostowfi, Nicki / Thompson, Paul M. / Braskie, Meredith N. / Alzheimer's Disease Neuroimaging Initiative et al. | 2018
- P653
-
O2‐13‐03: REGIONAL DISTRIBUTION OF WHITE MATTER HYPERINTENSITIES RELATED TO ALZHEIMER'S DISEASE RISK FACTORS IN THE ALFA COHORTSalvadó, Gemma / Brugulat-Serrat, Anna / Sudre, Carole H. / Grau, Oriol / Falcon, Carles / Cardoso, M. Jorge / Barkhof, Frederik / Molinuevo, José Luis / Gispert, Juan Domingo et al. | 2018
- P654
-
O2‐13‐05: COMORBIDITY OF CEREBROVASCULAR DISEASE AND AMYLOID‐β AND ITS INFLUENCE ON RATES OF COGNITIVE DECLINE AND NEURODEGENERATIONYassi, Nawaf / Hilal, Saima / Xia, Ying / Lim, Yen / Kuijf, Hugo J. / Fowler, Christopher / Yates, Paul A. / Chen, Christopher P. / Rowe, Christopher / Villemagne, Victor L. et al. | 2018
- P654
-
O2‐13‐04: WHITE MATTER HYPERINTENSITIES AND CSF BIOMARKERS IN RELATION TO CLINICAL SYMPTOM ONSET IN PRECLINICAL ALZHEIMER'S DISEASESoldan, Anja / Pettigrew, Corinne / Zhu, Yuxin / Singh, Baljeet / Fletcher, Evan / Martinez, Oliver / Wang, Mei-Cheng / DeCarli, Charlie S. / Albert, Marilyn S. et al. | 2018
- P655
-
O2‐13‐06: PITTSBURGH COMPOUND‐B BINDING IN WHITE MATTER HYPERINTENSITIES IS ASSOCIATED WITH LOSS OF WHITE MATTER INTEGRITY ON DTIZeydan, Burcu / Schwarz, Christopher G. / Lowe, Val J. / Reid, Robert I. / Przybelski, Scott A. / Lesnick, Timothy G. / Kremers, Walter K. / Senjem, Matthew L. / Kantarci, Orhun H. / Vemuri, Prashanthi et al. | 2018
- P656
-
O2‐14‐01: CHARACTERISTICS AND PROGRESS OF 320 SUBJECTS IN THE LONGITUDINAL EVALUATION OF FAMILIAL FRONTOTEMPORAL DEMENTIA SUBJECTS (LEFFTDS) PROTOCOLForsberg, Leah K. / Boeve, Bradley F. / Rosen, Howard J. / Boxer, Adam L. / Bove, Jessica / Brushaber, Danielle / Coppola, Giovanni / Dheel, Christina / Dickerson, Brad C. / Dickinson, Susan et al. | 2018
- P656
-
O2‐14‐02: THE CLINICAL SPECTRUM OF FRONTOTEMPORAL LOBAR DEGENERATION IN NORTH AMERICA: BASELINE CHARACTERISTICS OF THE FIRST 912 PARTICIPANTS FROM THE ADVANCING RESEARCH AND TREATMENT IN FTLD (ARTFL) CLINICAL RESEARCH CONSORTIUMHeuer, Hilary W. / Boxer, Adam L. / Rosen, Howard J. / Boeve, Bradley F. / Grossman, Murray / Dickerson, Brad C. / Appleby, Brian / Bordelon, Yvette M. / Brushaber, Danielle / Kimiko, Domoto-Reilly et al. | 2018
- P657
-
O2‐14‐03: A COMPARATIVE STUDY EXAMINING PREVALENCE OF LIFETIME PSYCHIATRIC DISORDERS AS A RISK FACTOR FOR BEHAVIORAL VARIANT FRONTOTEMPORAL DEMENTIA AND ALZHEIMER'S DISEASENunez, Nicolas A. / Yin, Shelly / McCarthy, Jill / Ducharme, Simon et al. | 2018
- P657
-
O2‐14‐04: IDENTIFYING BEHAVIORAL VARIANT FRONTOTEMPORAL DEMENTIA AMONG PATIENTS WITH A LATE‐ONSET FRONTAL LOBE SYNDROME: SUMMARY RESULTS OF THE LOF STUDYPijnenburg, Yolande A.L. / Vijverberg, Everard / Krudop, Welmoed A. / Gossink, Flora T. / Prins, Niels D. / Schouws, Sigfried / Teunissen, Charlotte E. / Barkhof, Frederik / van Berckel, Bart N.M. / Stek, Max L. et al. | 2018
- P658
-
O2‐14‐05: CLINICAL EFFECTS OF FRONTAL BEHAVIOR IMPAIRMENT IN NON‐DEMENTED INDIVIDUALS: CORTICAL THINNING AND COGNITIVE DECLINEKim, Seung Joo et al. | 2018
- P658
-
O2‐14‐06: DIFFERENCES BETWEEN SPORADIC AND FAMILIAL BEHAVIORAL VARIANT FTD IN ADVANCING RESEARCH AND TREATMENT FOR FTLD (ARTFL) CLINICAL RESEARCH CONSORTIUMBoxer, Adam L. / Heuer, Hilary W. / Wang, Ping / Rascovsky, Katya / Rosen, Howard J. / Boeve, Bradley F. / Grossman, Murray / Coppola, Giovanni / Dickerson, Brad C. / Bordelon, Yvette M. et al. | 2018
- P659
-
O2‐15‐01: THE DIFFERENTIAL INFLUENCE OF IMMUNE, ENDOCYTOTIC AND LIPID METABOLISM GENES ON AMYLOID DEPOSITION AND NEURODEGENERATION IN ALZHEIMER'S DISEASEFemminella, Grazia Daniela / Talib, Sophie / Harold, Denise / Williams, Julie / Edison, Paul et al. | 2018
- P660
-
O2‐15‐02: LONGITUDINAL COURSE OF PRECLINICAL AD USING THE A/T/N FRAMEWORKRoe, Catherine M. / Babulal, Ganesh M. / Fagan, Anne M. / Benzinger, Tammie L.S. / Stout, Sarah Holtz / Hassenstab, Jason / Gordon, Brian A. / Holtzman, Dave M. / Morris, John C. / Ances, Beau M. et al. | 2018
- P661
-
O2‐15‐04: ROBUST INDIVIDUALIZED PREDICTION MODELS WHICH ARE APPLICABLE ACROSS DIFFERENT COHORTSvan Maurik, Ingrid S. / Vos, Stephanie J.B. / Bos, Isabelle / Bouwman, Femke H. / Tijms, Betty M. / Teunissen, Charlotte E. / Barkhof, Frederik / Scheltens, Philip / Palmqvist, Sebastian / Hansson, Oskar et al. | 2018
- P661
-
O2‐15‐03: DIFFERENTIAL RISK FACTORS FOR PROGRESSION TO MCI/DEMENTIA BY AMYLOID‐BETA STATUSDang, Christa / Harrington, Karra D. / Lim, Yen / Yassi, Nawaf / Hickey, Martha / Ames, David / Rowe, Christopher C. / Villemagne, Victor L. / Masters, Colin L. / Maruff, Paul et al. | 2018
- P662
-
O2‐15‐05: CSF IMMUNE MARKERS PREDICT DECREASED AD SYMPTOM SEVERITY AND PROGRESSIONMeyer, Pierre-Francois / Savard, Melissa / Poirier, Judes / Breitner, John C.S. / Alzheimer's Disease Neuroimaging Initiative et al. | 2018
- P663
-
O2‐15‐06: CSF AMYLOID‐β PEPTIDES IN DEMENTIA WITH LEWY BODIES AND ALZHEIMER'S DISEASEvan Steenoven, Inger / Twaalfhoven, Harry / Van der Flier, Wiesje M. / Teunissen, Charlotte E. / Lemstra, Afina W. et al. | 2018
- P665
-
P2‐001: WITHDRAWN| 2018
- P665
-
P2‐002: SIB MAINTENANCE OF RESPONSE WITH MEMANTINE ADDED TO CHOLINESTERASE INHIBITORS: POOLED POST HOC ANALYSIS OF 2 RANDOMIZED CONTROLLED TRIALS IN PATIENTS WITH MODERATE TO SEVERE ADSchmitt, Frederick A. / Tariot, Pierre N. / Grossberg, George T. / Hendrix, Suzanne / Ellison, Noel / Kerolous, Majid et al. | 2018
- P665
-
P2‐003: ACETYLCHOLINESTERASE INHIBITOR THERAPY IN MILD COGNITIVE IMPAIRMENT: YES OR NO?Sokolow, Sophie / Marosi, Krisztina / Nho, Kwangsik / Rotter, Jerome I. / Apostolova, Liana G. / Alzheimer's Disease Neuroimaging Initiative et al. | 2018
- P666
-
P2‐004: COGNITIVE REHABILITATION WITH TRANSCRANIAL DIRECT CURRENT STIMULATION: EFFECT ON COGNITION IN MAJOR OR MINOR NEUROCOGNITIVE DISORDERS —A RANDOMISED CONTROLLED PRELIMINARY STUDYInagawa, Takuma / Yokoi, Yuma / Narita, Zui / Maruo, Kazushi / Okazaki, Mitsutoshi / Nakagome, Kazuyuki et al. | 2018
- P666
-
P2‐005: NEUROPLASTICITY‐BASED VISUAL ATTENTION TRAINING AND THE EXPRESSION OF ACETYLCHOLINE IN HEALTHY OLDER ADULTSVan Vleet, Thomas M. / de Villers-Sidani, Etienne / Cote, Jonathan / Merzenich, Michael / Rosa-Neto, Pedro / Kang, Min Su et al. | 2018
- P666
-
P2‐006: EFFECTS OF REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION ON COGNITIVE FUNCTION IN MILD COGNITIVE IMPAIRMENT: A SYSTEMATIC REVIEW AND META‐ANALYSISChou, Ying-hui et al. | 2018
- P667
-
P2‐008: EFFECTS OF LONG‐TERM TIBETAN GOUZHANG DANCES ON COGNITIVE FUNCTION ASSOCIATED WITH CEREBRAL BLOOD BLOW AND CEREBRAL REGIONS IN ELDERLY LIVING AT HIGH ALTITUDEZhu, Aiqin / Li, Guofeng / Zhong, Xin / Huang, Yuling / Meng, Jie et al. | 2018
- P667
-
P2‐007: STRUGGLING WITH POLYPHARMACY FOR DEMENTED PATIENTSKameyama, Yumi Umeda / Kojima, Taro / Ishii, Shinya / Yakabe, Mitsutaka / Urano, Tomohiko / Yamaguchi, Yasuhiro / Ogawa, Sumito / Akishita, Masahiro et al. | 2018
- P668
-
P2‐010: INVOLVEMENT OF ELEVATED NEUROINFLAMMATION IN KEY REGIONS OF THE PAIN PATHWAY IN NOCICEPTIVE PROCESSING IN ALZHEIMER'S DISEASEAman, Yahyah / Troakes, Claire / Ballard, Clive / Malcangio, Marzia et al. | 2018
- P668
-
P2‐009: CLINICAL TESTING OF LONGEVERON MESENCHYMAL STEM CELLS (LMSCS) TO TREAT ALZHEIMER'S DISEASEOliva, Anthony A. Jr. / Baumel, Benard / Brody, Mark / Perez, Carmen / Chisholm, Cristine / Medina, Audrey / Landman, Jonathan / McClain-Moss, Lisa / Alston, Tequesta / Hare, Joshua M. et al. | 2018
- P669
-
P2‐011: PHARMACOKINETIC‐PHARMACODYNAMIC MODELING OF THE THERAPEUTIC EFFECT OF ORAL P38 MAPK ALPHA ANTAGONISM ON EPISODIC MEMORY IN PATIENTS WITH EARLY ALZHEIMER'S DISEASE (AD)Chu, Hui-May / Prins, Niels D. / Ette, Ene / Alam, John et al. | 2018
- P669
-
P2‐013: STIMULATION OF CEREBRAL NEUROGENESIS WITH TRANSCATHETER INTRACEREBRAL LOW‐LEVEL LASER (LIGHT) THERAPY IN PATIENTS WITH ALZHEIMER'S DISEASEMaksimovich, Ivan V. et al. | 2018
- P669
-
P2‐012: IMPACT OF MUSIC THERAPY ON ANTIPSYCHOTIC PRESCRIPTION IN ALZHEIMER'S DISEASE OR RELATED SYNDROMES AMONG PATIENTS WITH NEUROPSYCHIATRIC SYMPTOMSArbus, Christophe / Billoux, Sophie / Thalamas, Claire / Rolland, Yves / Guetin, Stephane et al. | 2018
- P670
-
P2‐015: TOWARD AN UNDERSTANDING OF THE IMMUNOLOGICAL BASES OF THE EFFICACY OF RESVERATROL WITH RED WINE POLYPHENOLS IN PD WITH AD CHANGES WITH SUGGESTED TRIAL DESIGNBarber, Elizabeth K. et al. | 2018
- P670
-
P2‐014: STRATEGIC MEMORY ALZHEIMERS REHABILITATION TRAINING (SMART) MEMORY PROGRAM FOR AMNESTIC MILD COGNITIVE IMPAIRMENT (AMCI): REPORTING THE RESULTS OF A RANDOMIZED CLINICAL TRIALDenBoer, John William et al. | 2018
- P671
-
P2‐017: EFFECTS OF TECHNOLOGY‐ENABLED PHYSICAL ACTIVITY COUNSELLING ON INTRA‐INDIVIDUAL VARIABILITY AND OTHER MEASURES OF COGNITIVE PERFORMANCE AMONG ADULTS WITH KNEE OSTEOARTHRITISBest, John R. / Falck, Ryan S. / Li, Linda C. / Feehan, Lynne M. / Liu-Ambrose, Teresa et al. | 2018
- P671
-
P2‐016: WITHDRAWN| 2018
- P672
-
P2‐018: A PILOT CLINICAL TRIAL OF TRANSCRANIAL AND INTRANASAL PHOTOBIOMODULATION FOR COGNITIVE AND BEHAVIORAL FUNCTION, CEREBRAL PERFUSION, AND RESTING STATE FUNCTIONAL CONNECTIVITYChao, Linda L. et al. | 2018
- P673
-
P2‐019: IMPROVING CARE FOR FALLS IN DEMENTIA: DEVELOPMENT OF THE DIFRID INTERVENTIONAllan, Louise M. / Wheatley, Alison / Bamford, Claire et al. | 2018
- P673
-
P2‐020: THE EFFECTS OF MUSIC THERAPY ON COGNITIVE AND PSYCHIATRIC SYMPTOMS IN PATIENTS WITH ALZHEIMER'S DISEASELu, Jihui / Zhang, Jingnan / Mu, Haiyan / Zhang, Mei Champ / Xiong, Qian / Gao, Tian / Xie, Lijuan / Jin, Weiye / Cui, Mengnan / Gao, Maolong et al. | 2018
- P674
-
P2‐021: WITHDRAWN| 2018
- P674
-
P2‐022: INTERVENTIONS FOR SUBJECTIVE COGNITIVE DECLINE: SYSTEMATIC REVIEW AND META‐ANALYSISBhome, Rohan / Howard, Robert J. / Huntley, Jonathan D. / Berry, Alex J. et al. | 2018
- P674
-
P2‐023: MILD COGNITIVE IMPAIRMENT WITH A HIGH RISK OF PROGRESSION TO ALZHEIMER'S DISEASE DEMENTIA (MCI‐HR‐AD): EFFECT OF SOUVENAID® TREATMENT ON COGNITION AND 18F‐FDG PET SCANSManzano Palomo, Maria Sagrario Sr. / Caravaca, Belen Anaya / Balsa Breton, Maria Angeles / Castrillo, Sergio Muñiz / De La Morena Vicente, Maria Asuncion / Arce, Eduardo Castro / Alves Pérez, María Teresa et al. | 2018
- P675
-
P2‐024: REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION IN PRIMARY PROGRESSIVE APHASIAS AND BEHAVIORAL VARIANT FRONTOTEMPORAL DEMENTIA: A CASE SERIESMargolis, Seth A. / Festa, Elena K. / Korthauer, Laura E. / Gonsalves, Meghan / Oberman, Lindsay M. / Heindel, William C. / Ott, Brian R. et al. | 2018
- P675
-
P2‐025: THE EFFICACY OF COMPUTERIZED COGNITIVE TRAINING IN PATIENTS WITH VASCULAR COGNITIVE IMPAIRMENT, NO DEMENTIA (THE COG‐VACCINE STUDY): A RANDOMIZED CONTROLLED TRIALTang, Yi / Xing, Yi / Zhu, Zude / Yang, Jianwei / Li, Fang / Li, Fangyu / Jia, Jianping et al. | 2018
- P676
-
P2‐026: DIFFERENTIAL EFFECTS OF PHARMACOLOGIC AND NON‐PHARMACOLOGIC TREATMENTS OF ALZHEIMER'S DISEASE: A COMPREHENSIVE SUMMARY OF EVIDENCE AND META‐ANALYSISIvashchenko, Anna V. / Brooks, Logan / Tran, Zung Vu et al. | 2018
- P677
-
P2‐028: DONEPEZIL USE AND THE EMERGENCE OF COMORBIDITY IN PATIENTS WITH ALZHEIMER'S DEMENTIA: FINDINGS FROM REAL‐WORLD ‘BIG‐DATA’ IN JAPANKobayashi, Hiroyuki / Arai, Heii et al. | 2018
- P677
-
P2‐029: RATIONALE AND DESIGN OF A PROSPECTIVE, RANDOMIZED, DOUBLE‐BLIND, DOSE‐COMPARISON SAFETY AND TOLERABILITY STUDY OF GRF6019 IN MILD‐TO‐MODERATE ALZHEIMER'S DISEASEHannestad, Jonas / Stephens, Darby / Koborsi, Katie / Braithwaite, Steven P. / Jackson, Sam et al. | 2018
- P677
-
P2‐027: TARGET ENGAGEMENT IN A PHASE II CLINICAL TRIAL OF AAV2‐NGF GENE THERAPY FOR ALZHEIMER'S DISEASECastle, Michael J. / Baltanas, Fernando Calvo / Kovacs, Imre / Nagahara, Alan H. / Bankiewicz, Krystof S. / Barba, David / Tuszynski, Mark H. et al. | 2018
- P678
-
P2‐031: THE EVOLUTION OF COGNITION TRIALS: 2003‐2018Peroutka, Stephen J. et al. | 2018
- P678
-
P2‐032: ITI‐007 (LUMATEPERONE) FOR THE TREATMENT OF AGITATION IN PATIENTS WITH DEMENTIA, INCLUDING ALZHEIMER'S DISEASESatlin, Andrew / Vanover, Kim / Glass, Steven / Saillard, Jelena / Mates, Sharon / Weingart, Michal / Davis, Robert E. et al. | 2018
- P678
-
P2‐030: INTENSIVE LANGUAGE TRAINING COMBINED WITH TRANSCRANIAL STIMULATION IN PATIENTS WITH LOGOPENIC APHASIAFerrari, Jesica Sr. / Borovinsky, Geraldine Sr. / Alejandra Suarez, Diana María Sr. / Birba, Agustina Sr. / Pontello, Noelia / Manes, Facundo Sr. / Martínez-Cuitiño, Macarena / Zimerman, Máximo Sr. et al. | 2018
- P679
-
P2‐033: AXS‐05 (DEXTROMETHORPHAN/BUPROPION): AN INNOVATIVE TREATMENT IN CLINICAL DEVELOPMENT FOR AGITATION ASSOCIATED WITH ALZHEIMER'S DISEASEO'Gorman, Cedric / Jones, Amanda / Tabuteau, Herriot et al. | 2018
- P679
-
P2‐034: ENHANCING MEDICATION MANAGEMENT THROUGH THE USE OF CLINICAL DECISION SUPPORT SOFTWARE PLATFORMSZelek, Mark C. / Keine, Dorothy / Walker, John Q. II / Sabbagh, Marwan N. et al. | 2018
- P680
-
P2‐036: WHY AND HOW WE THINK THAT CLINICAL TRIALS OF THERAPIES FOR ALZHEIMER'S DISEASE CAN BE SUCCESSFUL: A SIMULATION PLATFORM FOR PRECLINICAL ADCaputo, Angelika / Feller, Chrystel / Paule, Ines / Racine, Amy / Lopez-Lopez, Cristina / Graf, Ana et al. | 2018
- P680
-
P2‐035: PILOT VALIDATION OF AN ELECTRONIC ALZHEIMER'S DISEASE ASSESSMENT SCALE: COGNITIVE SUBSCALE (EADAS‐COG)Solomon, Todd M. / Barbone, Jordan M. / Miller, David S. / Feaster, H Todd et al. | 2018
- P680
-
P2‐037: APABETALONE (AN EPIGENETIC BET‐INHIBITOR SMALL MOLECULE) AND EFFECTS ON COGNITION IN DIABETES PATIENTS WITH CARDIOVASCULAR DISEASECummings, Jeffrey L. / Johansson, Jan O. / Kulikowski, Ewelina / Wong, Norman C.W. / Halliday, Christopher / Lebioda, Ken / Winblad, Bengt / Zetterberg, Henrik / Kalantar-Zadeh, Kam / Nicholls, Stephen J. et al. | 2018
- P681
-
P2‐039: INNOVATIVE SOFTWARE PLATFORM FOR TARGETING DYSREGULATED EPIGENETIC PATHWAYS AND IDENTIFYING NOVEL THERAPEUTIC APPROACHES IN ALZHEIMER'S DISEASE: A COMPREHENSIVE APPROACHAnderson, Loretta R. / Pollack, Andrew A. et al. | 2018
- P681
-
P2‐038: PROBLEMS AND ISSUES OF CLINICAL SITES IN INDUSTRY SPONSORED TRIALS AND WITH CLINICAL RESEARCH ORGANIZATIONS: A EUROPEAN ALZHEIMER DISEASE CONSORTIUM (EADC) SURVEYHausner, Lucrezia / Dinu-Biringer, Ramona / Frölich, Lutz et al. | 2018
- P682
-
P2‐040: THE EFFECT OF BSA NANOPARTICLE LOADED CURCUMIN ON MEMORY AND HIPPOCAMPAL MMP‐2, 9 AND MAPKS IN ADULT MICEMoosavi, Maryam / SoukhakLari, Roksana / Moezi, Leila / Pirsalami, Fatema et al. | 2018
- P682
-
P2‐041: OPTIMIZATION AND VALIDATION OF A SE‐HPLC METHOD FOR ANALYZING AMYLOID BETA OLIGOMERSFontana, Igor C. / Silva da Rocha, Andreia / Zimmer, Aline R. / Gosmann, Grace / Rodrigues, Yuri Elias / Souza, Diogo O. / Miron, Diogo / Zimmer, Eduardo R. et al. | 2018
- P683
-
P2‐043: UNDERSTANDING THE INTERACTION OF APOLIPOPROTEIN E WITH AMYLOID‐BETA IN THE PRESENCE OF EPIGALLOCATECHIN GALLATE AND ITS DERIVATIVESSundar Ganesh, Hashwin Vijay / Singh, Anthony / Bates, Allan / Kerman, Kagan et al. | 2018
- P683
-
P2‐042: COCKTAIL OF FLAVONOIDS AND ANTHOCYANINS PROTECTS AGAINST DEMENTIA AND BIOCHEMICAL CHANGES IN A SCOPOLAMINE MODEL IN DROSOPHILA: AN EFFECIENT PRIMARY SCREEN FOR THERAPEUTICSChandran, Girish / Chauhan, Jyoti Bala et al. | 2018
- P683
-
P2‐044: HIGH‐THROUGHPUT SCREENING TO IDENTIFY BLOOD‐BRAIN BARRIER INTEGRITY ENHANCERS TO RECTIFY VASCULAR AMYLOID TOXICITY: FROM IN VITRO TO IN VIVO STUDIESKaddoumi, Amal et al. | 2018
- P684
-
P2‐045: THE MODEL‐AD CONSORTIUM PRECLINICAL TESTING PIPELINE: PHARMACOKINETICS AND PHARMACODYNAMICS OF PROPHYLACTIC TREATMENT WITH LEVETIRACETAM IN THE 5XFAD MOUSE MODEL OF ALZHEIMER'S DISEASESukoff Rizzo, Stacey J. / Quinney, Sara K. / Onos, Kristen D. / Keezer, Kelly J. / Jones, David R. / Masters, Andrea R. / Metzger, Ingrid F. / Meyer, Jill A. / Peters, Jonathan / Persohn, Scott C. et al. | 2018
- P684
-
P2‐046: CURCUMIN DERIVATIVE WITH C‐4 SUBSTITUENT ATTENUATED AMYLOID DEPOSITION, BUT DID NOT AFFECT TAU PATHOLOGY IN MOUSE MODELSYanagisawa, Daijiro / Taguchi, Hiroyasu / Durani, Lina Wati / Hamezah, Hamizah Shahirah / Tooyama, Ikuo et al. | 2018
- P685
-
P2‐049: WITHDRAWN| 2018
- P685
-
P2‐050: DECREASE IN AMYLOID PLAQUE FORMATION BY DISEASE‐MODIFYING DRUG SAK3 IN APP KNOCK‐IN MICEFukunaga, Kohji / Izumi, Hisanao / Shinoda, Yasuharu / Yabuki, Yasushi / Saito, Takashi / Saido, Takaomi C. et al. | 2018
- P685
-
P2‐048: HUMANIZED PMN310 SHOWS ENHANCED THERAPEUTIC POTENTIAL BY BINDING TOXIC LOW MOLECULAR WEIGHT Aβ OLIGOMERS WHILE AVOIDING ARIA‐RELATED BINDING TO Aβ DEPOSITS IN AD PATIENT BRAINSKaplan, Johanne / Gibbs, Ebrima / Silverman, Judith M. / Wang, Jing / Peng, Xubiao / Plotkin, Steven S. / Cashman, Neil R. et al. | 2018
- P685
-
P2‐047: WITHDRAWN| 2018
- P686
-
P2‐051: INCREASED BRAIN MRNA EXPRESSION OF BETA AMYLOID DEGRADING ENZYMES WITH SOMATOSTATIN‐4 RECEPTOR AGONIST TREATMENT IN 3XTG MICESandoval, Karin E. / Umbaugh, David S. / Witt, Ken A. et al. | 2018
- P686
-
P2‐052: SELECTIVE SOMATOSTATIN RECEPTOR SUBTYPE‐4 AGONISTS FOR ALZHEIMER'S DISEASE TREATMENTWitt, Ken A. / Farr, Susan A. / Sandoval, Karin E. et al. | 2018
- P686
-
P2‐053: ENGINEERED ANTIBODIES TO TREAT OR PREVENT ALZHEIMER'S DISEASECrespi, Gabriela A.N. / Watt, Andrew D. / Hancock, Nancy C. / Nero, Tracy / Hermans, Stefan / Barnham, Kevin J. / Parker, Michael W. / Miles, Luke A. et al. | 2018
- P687
-
P2‐054: MOLECULAR IMAGING AND TREATMENT OF ALZHEIMER'S DISEASE BY DEVELOPING AMYLOID‐β OLIGOMER ANTIBODIES THAT CROSS THE BLOOD‐BRAIN BARRIERSanjo, Nobuo / Kuwahara, Hiroya / Nagata, Tetsuya / Nishida, Yoichiro / Amano, Akiko / Furukawa, Fumiko / Hirata, Kousei / Maruoka, Hiroyuki / Nakakido, Makoto / Kohei, Tsumoto et al. | 2018
- P687
-
P2‐055: Aβ OLIGOMER ELIMINATION IMPROVES COGNITIVE AND MOTORIC IMPAIRMENT IN DIFFERENT ALZHEIMER'S DISEASE MOUSE MODELS AFTER ORAL ADMINISTRATIONSchemmert, Sarah / Schartmann, Anna Elena / Kutzsche, Janine / Willuweit, Antje / Willbold, Dieter et al. | 2018
- P687
-
P2‐056: TARGETING ISOASPARTATE‐MODIFIED Aβ: A DIFFERENTIAL APPROACH OF PASSIVE IMMUNOTHERAPYRahfeld, Jens-Ulrich / Piechotta, Anke / Gnoth, Kathrin / Rossner, Steffen / Nykiel, Vera / Cynis, Holger / Demuth, Hans-Ulrich / Schilling, Stephan et al. | 2018
- P688
-
P2‐057: REMOVAL OF Aβ OLIGOMERS FROM THE BLOOD USING HOLLOW FIBERS: A POTENTIAL THERAPEUTIC SYSTEM FOR ALZHEIMER'S DISEASESaito, Yuta / Kobayakawa, Moe / Sakata, Miwa / Kawaguchi, Kazunori / Morikawa, Hiroshi Kawachi / Ohashi, Norimi / Hiki, Yoshiyuki / Kato, Masao / Hasegawa, Midori / Yuzawa, Yukio et al. | 2018
- P688
-
P2‐058: THE ROLE OF BACE1 INHIBITION ON Aβ PATHOLOGY IN YOUNG AND AGED PDAPP MICEYang, Zhixiang / Thompson, Linda / Boggs, Leonard N. / Racke, Margaret M. / Riddell, David R. / McKinzie, David L. et al. | 2018
- P689
-
P2‐061: NEGATIVE ALLOSTERIC MODULATION OF MGLU5 RECEPTOR RESCUES SPATIAL MEMORY LOSS IN Aβ40 RAT MODEL OF ALZHEIMER DISEASEDhull, Dinesh Kumar / Kumar, Anil et al. | 2018
- P689
-
P2‐060: BRAIN‐FREE FATTY ACID RECEPTOR ‐1 (GPR40): A NOVEL TARGET FOR DEMENTIASona, Chandan / Yadav, Prem Narayan et al. | 2018
- P689
-
P2‐059: BDNF GENE DELIVERY INTO THE ENTORHINAL CORTEX IN RATS: SAFETY‐TOXICITY DATANagahara, Alan H. / Graham, Lori / Alisady, Ali D. / Staufenberg, Eileen / Elma, Talia D. / Kovacs, Imre / Tuszynski, Mark H. et al. | 2018
- P690
-
P2‐063: A NOVEL IMMUNOTHERAPEUTIC APPROACH TO SIMULTANEOUSLY TARGET BEHAVIORAL STRESS AND DOWNSTREAM PATHOLOGIES IN ALZHEIMER'S DISEASEFutch, Hunter S. / Kuhn, Mike Zino / Levites, Yona / Moore, Brenda D. / Janus, Christopher / Golde, Todd E. et al. | 2018
- P690
-
P2‐062: RILUZOLE AS AN EARLY THERAPEUTIC AGENT FOR ALZHEIMER'S DISEASEHascup, Kevin N. / Broderick, Sarah O. / Britz, Jesse / Hascup, Erin R. et al. | 2018
- P691
-
P2‐066: INNATE IMMUNITY STIMULATION VIA TOLL‐LIKE RECEPTOR 9 IN A TAUOPATHY MOUSE MODEL, RTG4510Scholtzova, Henrieta / Patel, Akash G. / Lyo, Helen Keizhen / Cho, Elizabeth L. / Allington, Grant / Sun, Yanjie / Gamallo-Lana, Begona / Mar, Adam / Wisniewski, Thomas et al. | 2018
- P691
-
P2‐064: BENEFICAL PROPERTIES OF A HUMAN PLASMA FRACTION FOR AGE‐RELATED COGNITIVE DISORDERSGallager, Ian / Castro, Marian / Alcantara-Lee, Raniel / Estrada, Raul / Huber, Nina / Kheifets, Viktoria / Czirr, Eva / Minami, S Sakura / Braithwaite, Steven P. et al. | 2018
- P691
-
P2‐065: EFFECT OF NEUROGENIC COMPOUND NSI‐189 ON INDICES OF COGNITION AND ANXIETY IN A MOUSE MODEL (5XFAD) OF ALZHEIMER'S DISEASEJolivalt, Corinne G. / Marquez, Alexandra / Quach, David M. / Johe, Karl K. et al. | 2018
- P692
-
P2‐068: DATA‐DRIVEN PROPAGATION MODELING OF PET‐DERIVED ALZHEIMER'S PATHOLOGY IN A PRECLINICAL COHORTHwang, Seong Jae / Ravi, Sathya / Adluru, Nagesh / Bendlin, Barbara B. / Johnson, Sterling C. / Singh, Vikas et al. | 2018
- P692
-
P2‐067: WHAT WOULD BE THE LIKELY IMPACT OF AN INTERVENTION THAT SUCCESSFULLY PREVENTED NEOCORTICAL ACCUMULATION OF NEURITIC AMYLOID PLAQUES AND A HIGH BRAAK STAGE? THOUGHT EXPERIMENTS USING DATA FROM THE NUN STUDY (NS) AND THE HONOLULU‐ASIA AGING STUDYWhite, Lon R. / Edland, Steven D. / Hemmy, Laura S. / Flanagan, Margaret E. / Liu, Catherine / Feng, Jing / Himmer, Elyssa K. / Montine, Thomas J. et al. | 2018
- P693
-
P2‐070: CHRONIC CEREBRAL HYPOPERFUSION INCREASES AMYLOID PLAQUES BY ACCELERATING AMYLOID BETA AGGREGATION IN APP/PS1 TRANSGENIC MICEBannai, Taro / Iwata, Atsushi / Mano, Tatsuo / Ohtomo, Ryo / Ohtomo, Gaku / Hashimoto, Tadafumi / Iwatsubo, Takeshi / Toda, Tatsushi et al. | 2018
- P693
-
P2‐069: DISTINCT ROLE OF CONSTANT LIGHT AND DARKNESS IN Aβ42 PATHOLOGIC DROSOPHILAChou, Chih-Ho / Chang, Chi-Yuan / Chiang, HsuehCheng et al. | 2018
- P694
-
P2‐072: A STATISTICAL METHOD FOR DETERMINING BIOMARKER THRESHOLD FOR ALZHEIMER'S DISEASELi, Yan / Wang, Guoqiao / Xiong, Chengjie / McDade, Eric / Fagan, Anne M. / Gordon, Brian A. / Benzinger, Tammie L.S. / Aschenbrenner, Andrew J. / Hassenstab, Jason / Bateman, Randall J. et al. | 2018
- P694
-
P2‐071: COMPARING CEREBRAL WHITE MATTER, CEREBELLAR, AND PONTINE REFERENCE REGIONS TO CHARACTERIZE FLORBETAPIR PET MEASUREMENTS OF AMYLOID‐β BURDEN IN PSEN1 E280A MUTATION CARRIERS AND NONCARRIERS FROM THE COLOMBIAN AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE KINDREDGhisays, Valentina / Protas, Hillary / Chen, Yinghua / DeMarco, Eric L. / Tariot, Pierre N. / Langbaum, Jessica B. / Quiroz, Yakeel T. / Lopera, Francisco / Reiman, Eric M. / Chen, Kewei et al. | 2018
- P695
-
P2‐073: FEASIBILITY OF QUANTIFYING AMYLOID BURDEN USING VOLUMETRIC MRI DATA: PRELIMINARY FINDINGS BASED ON THE DEEP LEARNING 3D CONVOLUTIONAL NEURAL NETWORK APPROACHYuan, Ye / Wang, Zhangyang / Lee, Wendy / Thiyyagura, Pradeep / Reiman, Eric M. / Chen, Kewei et al. | 2018
- P695
-
P2‐075: CHARACTERISATION OF THE BINDING PROFILE OF THE COMPOUND PTP‐TFE TOWARD BETA‐AMYLOID (Aβ) AGGREGATES SHOWS PREFERRED BINDING TO OLIGOMERSZhao, Yanyan / Brener, Oleksandr / Aigbirhio, Franklin I. et al. | 2018
- P695
-
P2‐074: IMPAIRED CSF CLEARANCE AND BRAIN AMYLOID IN ALZHEIMER'S DISEASE: A MULTI‐TRACER PET STUDYLi, Yi / de Leon, Mony J. / Tsui, Wai / Pirraglia, Elizabeth / Glodzik, Lidia / Chen, Jingyun / Osorio, Ricardo S. / Rusinek, Henry / NYU School of Medicine, CBH et al. | 2018
- P696
-
P2‐076: A NOVEL ALTERNATIVE MODEL TO MMRM AS THE PRIMARY MODEL FOR SPORADIC AD CLINICAL TRIALS: THE PROPORTIONAL MMRMWang, Guoqiao / Xiong, Chengjie / McDade, Eric / Li, Yan / Aschenbrenner, Andrew J. / Hassenstab, Jason / Berry, Scott / Bateman, Randall J. et al. | 2018